1. Beyond First Line CDK4/6 Inhibitors (CDK4/6i) and Aromatase Inhibitors (AI) in Patients with Oestrogen Receptor Positive Metastatic Breast Cancer (ER+ MBC): The Guy's Cancer Centre Experience. Issue 4 (April 2022) Authors: Gousis, C.; Michoglou, K.; Lowe, H.; Kapiris, M.; Angelis, V. Journal: Clinical oncology Issue: Volume 34:Issue 4(2022) Page Start: e178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First line anti-PD1 checkpoint inhibitor in the management of patients with advanced non-small cell lung cancer: the Kent Cancer Network experience. (January 2019) Authors: Angelis, V.; Hunter, S.; Shah, R. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Haematological Toxicity Surveillance in the Management of Patients with ER-positive Metastatic Breast Cancer Receiving Palbociclib: is Nurse-led Review on Day 14 Necessary?. Issue 7 (July 2019) Authors: Angelis, V.; Parsons, E.; Harper-Wynne, C. Journal: Clinical oncology Issue: Volume 31:Issue 7(2019) Page Start: e105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Real world treatment and outcomes in patients with EGFR mutation positive advanced non-small cell lung cancer: the Kent Cancer Network experience. (January 2019) Authors: Angelis, V.; Fenton, M.; Hunter, S.; Shah, R. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Systemic therapies post progression on CDK4/6 inhibitors in patients with oestrogen receptor positive metastatic breast cancer: Real world data from Guy's Cancer Centre. (November 2022) Authors: Gousis, C.; Michoglou, K.; Lowe, H.; Akay, M.; Kapiris, M.; Angelis, V. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Use of pembrolizumab in previously treated patients with advanced non-small cell lung cancer: the Kent Cancer Network experience. (January 2019) Authors: Hunter, S.; Angelis, V.; Shah, R. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗